30 assets in Inflammatory Disease

Therapeutic assets addressing Inflammatory Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Sufentanyl Inflammatory Disease	The First Affiliated Hospital with Nanjing Medical University	P4	BB (64)
Oxycodone Inflammatory Disease	The First Affiliated Hospital with Nanjing Medical University	P4	B (63)
Colchicinum Inflammatory Disease	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	P3	B (62)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Inflammatory Disease	University Tunis El Manar	P3	B (60)
Minocycline Inflammatory Disease	King's College London	P3	B (60)
Celecoxib Inflammatory Disease	Universiteit Antwerpen	P3	B (58)
Alemtuzumab Inflammatory Disease	Paul Szabolcs	P2	CCC (53)
Dapiglutide Inflammatory Disease	University Hospital, Gentofte, Copenhagen	P2	CCC (53)
Fludarabine Inflammatory Disease	Paul Szabolcs	P2	CCC (53)
Hydroxyurea Inflammatory Disease	Paul Szabolcs	P2	CCC (53)
Infliximab Inflammatory Disease	Massachusetts General Hospital	P2	CCC (53)
Melphalan Inflammatory Disease	Paul Szabolcs	P2	CCC (53)
Thiotepa Inflammatory Disease	Paul Szabolcs	P2	CCC (53)
Disulfiram Inflammatory Disease	University of Oklahoma	P2	CCC (50)
Black Chokeberry Extract In Capsules With 18% Standardization Of The Anthocyanins Content Inflammatory Disease	Poznan University of Physical Education	P1/2	CCC (48)
Naltrexone Inflammatory Disease	Truway Health, Inc.	P1/2	CCC (48)
Gly-Low Inflammatory Disease	Hoskinson Health and Wellness Clinic	Early P1	CC (41)
Ae-Peanut Inflammatory Disease	University of Barcelona	N/A	D (30)
Dexmedetomidine Inflammatory Disease	Samsung Medical Center	N/A	D (30)
Iron(Ii) Sulphate (1:1), Heptahydrate Inflammatory Disease	Linda Malan	N/A	D (30)
Isis-681257 (Galnac3--Conjugated Aso Targeting Human Lipoprotein (A) ) Inflammatory Disease	University Medical Centre Ljubljana	N/A	D (30)
Lidocaine Inflammatory Disease	University Tunis El Manar	N/A	D (30)
Nepenthe Inflammatory Disease	Samsung Medical Center	N/A	D (30)
Olea Europaea Oil Inflammatory Disease	Mucosa Innovations, S.L.	N/A	D (30)
Trimethylglycine Inflammatory Disease	Mucosa Innovations, S.L.	N/A	D (30)
Ulinastatin Inflammatory Disease	Beijing Tiantan Hospital	N/A	D (30)
Walnut Oil Inflammatory Disease	University of Illinois at Urbana-Champaign	N/A	D (30)
Xylitol Inflammatory Disease	Mucosa Innovations, S.L.	N/A	D (30)
Afa-281 Inflammatory Disease	Afasci Inc	P1	NR ()
Risperidone Inflammatory Disease	Hasanuddin University	P2	NR ()